CT for monitoring cryotherapy

American Journal of Roentgenology

Volumn 166, Issue 4, 1996, Pages 853-855

  Saliken, John C ^a   McKinnon, J Gregory ^a   Gray, Robin ^a  

^a FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID NITROGEN;

AGED; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; METASTASIS; PATIENT MONITORING; PRIORITY JOURNAL; RECTUM CARCINOMA;

EID: 0029879090     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.166.4.8610562     Document Type: Article

References (8)

1. Matsumoto R, Selig AM, Colucci VM, Jolesz FA. MR monitoring during cryotherapy in the liver: predictability of histologic outcome. J Magn Reson Imaging 1993,3:770-776
2. Gage AA Cryosurgery in the treatment of cancer Surgery 1992,174:73-92
3. Onik G, Kane R, Steele G, et al. Monitoring hepatic cryosurgery with sonography AJR 1986;147:665-669
4. Onik G, Cobb C, Cohen J, Zabkar J, Porterfield B. US characteristics of frozen prostate. Radiology 1988,168:629-631
5. Miller RJ, Cohen JK, Merlotti LA. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology 1994,44:170-174
6. Bahn DK, Lee F, Solomon MH, Gontina H, Klionsky D, Lee FT. Prostate cancer: US guided percutaneous cryoablation. Radiology 1994;194:551-556
7. Schenck JF, Jolesz FA, Roemer PB, et al. Superconducting open configuration MR imaging system for image-guided therapy. Radiology 1995; 195:805-814
8. Hanno P, Brandes S, Stern R, Seidmon EJ. Persistence of histologically viable appearing prostate tissue after cryosurgery. Proc Am Urol Assoc 1995;153.supplement 503A